| http://www.w3.org/ns/prov#value | - utologous tolerogenic dendritic cells for RA (AUTODECRA trial)Challenges for design of tolDC trialsFuture perspectives and concluding remarksAcknowledgementsDisclosureReferencesIn addition to issues relating to the development and manufacture of tolDC for clinical application, there are a number of challenges relating to the design of clinical trials.
|
